-
公开(公告)号:US20170275264A1
公开(公告)日:2017-09-28
申请号:US15452430
申请日:2017-03-07
申请人: Yves AUBERSON , Mark Gary BOCK , Dario BRAGA , Marco CURZI , Stephanie Kay DODD , Stefano Luca GIAFFREDA , Haiyang JIANG , Piotr KARPINSKI , Thomas J. TROXLER , Tie-Lin WANG , Xiaoyang WANG , Xuechun ZHANG
发明人: Yves AUBERSON , Mark Gary BOCK , Dario BRAGA , Marco CURZI , Stephanie Kay DODD , Stefano Luca GIAFFREDA , Haiyang JIANG , Piotr KARPINSKI , Thomas J. TROXLER , Tie-Lin WANG , Xiaoyang WANG , Xuechun ZHANG
IPC分类号: C07D401/04 , C07D403/04 , C07C57/15 , C07C59/265 , A61K31/496 , A61K31/501
CPC分类号: C07D401/04 , A61K31/496 , A61K31/501 , C07B2200/13 , C07C57/15 , C07C59/265 , C07D403/04
摘要: The invention relates to compound of the formula I or a salt thereof, wherein the substituents are as defined in the specification; to its preparation, to its use as medicament and to medicaments comprising it.
-
公开(公告)号:US20160244426A1
公开(公告)日:2016-08-25
申请号:US15049739
申请日:2016-02-22
申请人: Yves AUBERSON , Mark Gary BOCK , Dario BRAGA , Marco CURZI , Stephanie Kay DODD , Stefano Luca GIAFFREDA , Hayang JIANG , Piotr KARPINSKI , Thomas J. TROXLER , Tie-Lin WANG , Xiaoyang WANG , Xuechun ZHANG
发明人: Yves AUBERSON , Mark Gary BOCK , Dario BRAGA , Marco CURZI , Stephanie Kay DODD , Stefano Luca GIAFFREDA , Hayang JIANG , Piotr KARPINSKI , Thomas J. TROXLER , Tie-Lin WANG , Xiaoyang WANG , Xuechun ZHANG
IPC分类号: C07D401/04 , A61K31/496 , A61K31/501
CPC分类号: C07D401/04 , A61K31/496 , A61K31/501 , C07B2200/13 , C07C57/15 , C07C59/265 , C07D403/04
摘要: The invention relates to compound of the formula I or a salt thereof, wherein the substituents are as defined in the specification; to its preparation, to its use as medicament and to medicaments comprising it.
-
公开(公告)号:US20150218127A1
公开(公告)日:2015-08-06
申请号:US14685926
申请日:2015-04-14
申请人: Yves AUBERSON , Mark Gary BOCK , Dario BRAGA , Marco CURZI , Stephanie Kay DODD , Stefano Luca GIAFFREDA , Hayang JIANG , Piotr KARPINSKI , Thomas J. TROXLER , Telin WANG , Xiaoyang WANG , Xuechun ZHANG
发明人: Yves AUBERSON , Mark Gary BOCK , Dario BRAGA , Marco CURZI , Stephanie Kay DODD , Stefano Luca GIAFFREDA , Hayang JIANG , Piotr KARPINSKI , Thomas J. TROXLER , Telin WANG , Xiaoyang WANG , Xuechun ZHANG
IPC分类号: C07D401/04 , A61K31/496 , A61K31/501
CPC分类号: C07D401/04 , A61K31/496 , A61K31/501 , C07B2200/13 , C07C57/15 , C07C59/265 , C07D403/04
摘要: The invention relates to compound of the formula I or a salt thereof, wherein the substituents are as defined in the specification; to its preparation, to its use as medicament and to medicaments comprising it.
摘要翻译: 本发明涉及式I化合物或其盐,其中取代基如说明书中所定义; 作为其制备,用作药物和包含它的药物。
-
公开(公告)号:US20140171363A1
公开(公告)日:2014-06-19
申请号:US14188647
申请日:2014-02-24
申请人: David Weninger BARNES , Gregory Raymond BEBERNITZ , Kevin CLAIRMONT , Scott Louis COHEN , Robert Edson DAMON, II , Robert Francis DAY , Stephanie Kay DODD , Christoph GAUL , Hatice Belgin GULGEZE EFTHYMIOU , Monish JAIN , Rajeshri Ganesh KARKI , Louise Clare KIRMAN , Kai LIN , Justin Yik Ching MAO , Tajesh Jayprakash PATEL , Brian Kenneth RAYMER , SU Liansheng
发明人: David Weninger BARNES , Gregory Raymond BEBERNITZ , Kevin CLAIRMONT , Scott Louis COHEN , Robert Edson DAMON, II , Robert Francis DAY , Stephanie Kay DODD , Christoph GAUL , Hatice Belgin GULGEZE EFTHYMIOU , Monish JAIN , Rajeshri Ganesh KARKI , Louise Clare KIRMAN , Kai LIN , Justin Yik Ching MAO , Tajesh Jayprakash PATEL , Brian Kenneth RAYMER , SU Liansheng
IPC分类号: A61K31/542 , A61K31/4184 , C07D235/12 , C07D403/04 , C07D405/04 , C07D235/30 , C07D235/16 , C07D405/14 , A61K31/496 , C07D263/57 , A61K31/423 , C07D209/24 , A61K31/404 , C07D413/12 , A61K31/5377 , C07D513/04 , A61K45/06 , C07D235/08
CPC分类号: A61K31/542 , A61K9/0014 , A61K9/0019 , A61K9/0095 , A61K9/08 , A61K9/1075 , A61K31/404 , A61K31/4184 , A61K31/423 , A61K31/496 , A61K31/5377 , A61K45/06 , C07D209/24 , C07D215/36 , C07D235/08 , C07D235/12 , C07D235/16 , C07D235/18 , C07D235/30 , C07D263/57 , C07D401/04 , C07D401/12 , C07D403/04 , C07D405/04 , C07D405/14 , C07D413/12 , C07D471/04 , C07D513/04 , C12N9/93 , C12Y604/01002
摘要: The present invention provides compounds of formula (I); or pharmaceutically acceptable salts thereof, wherein the variables are defined as herein. The present invention provides a method for manufacturing the compounds of formula (I), their therapeutic uses, combinations with other of pharmacologically active agents, and a pharmaceutical compositions.
摘要翻译: 本发明提供式(I)化合物; 或其药学上可接受的盐,其中变量如本文所定义。 本发明提供了制备式(I)化合物,其治疗用途,与其他药理学活性剂的组合以及药物组合物的方法。
-
公开(公告)号:US20120028969A1
公开(公告)日:2012-02-02
申请号:US13189760
申请日:2011-07-25
申请人: David Weninger BARNES , Gregory Raymond BEBERNITZ , Kevin CLAIRMONT , Scott Louis COHEN , Robert Edson DAMON , Robert Francis DAY , Stephanie Kay DODD , Christoph GAUL , Hatice Belgin GULGEZE EFTHYMIOU , Monish JAIN , Rajeshri Ganesh KARKI , Louise Clare KIRMAN , Kai LIN , Justin Yik Ching MAO , Tajesh Jayprakash PATEL , Brian Kenneth RAYMER , Liansheng SU
发明人: David Weninger BARNES , Gregory Raymond BEBERNITZ , Kevin CLAIRMONT , Scott Louis COHEN , Robert Edson DAMON , Robert Francis DAY , Stephanie Kay DODD , Christoph GAUL , Hatice Belgin GULGEZE EFTHYMIOU , Monish JAIN , Rajeshri Ganesh KARKI , Louise Clare KIRMAN , Kai LIN , Justin Yik Ching MAO , Tajesh Jayprakash PATEL , Brian Kenneth RAYMER , Liansheng SU
IPC分类号: A61K31/542 , A61K31/5365 , A61K31/5377 , A61K31/4985 , A61K31/47 , A61K31/4245 , A61K31/4184 , A61K31/405 , C07D513/04 , C07D498/04 , C07D413/12 , C07D471/04 , C07D215/00 , C07D235/04 , C07D209/04 , A61P31/12 , A61P3/10 , A61P3/08 , A61P3/04 , A61P3/06 , A61P3/00 , C12N9/99
CPC分类号: A61K31/542 , A61K9/0014 , A61K9/0019 , A61K9/0095 , A61K9/08 , A61K9/1075 , A61K31/404 , A61K31/4184 , A61K31/423 , A61K31/496 , A61K31/5377 , A61K45/06 , C07D209/24 , C07D215/36 , C07D235/08 , C07D235/12 , C07D235/16 , C07D235/18 , C07D235/30 , C07D263/57 , C07D401/04 , C07D401/12 , C07D403/04 , C07D405/04 , C07D405/14 , C07D413/12 , C07D471/04 , C07D513/04 , C12N9/93 , C12Y604/01002
摘要: The present invention provides compounds of formula (I); or pharmaceutically acceptable salts thereof, wherein the variables are defined as herein. The present invention provides a method for manufacturing the compounds of formula (I), their therapeutic uses, combinations with other of pharmacologically active agents, and a pharmaceutical compositions.
摘要翻译: 本发明提供式(I)化合物; 或其药学上可接受的盐,其中变量如本文所定义。 本发明提供了制备式(I)化合物,其治疗用途,与其他药理学活性剂的组合以及药物组合物的方法。
-
6.COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1 审中-公开
标题翻译: 抑制ABL1,ABL2和BCR-ABL1活性的化合物和组合物公开(公告)号:US20140343086A1
公开(公告)日:2014-11-20
申请号:US14448363
申请日:2014-07-31
申请人: Stephanie Kay DODD , Pascal FURET , Robert Martin GROTZFELD , Wolfgang JAHNKE , Darryl Brynley JONES , Paul William MANLEY , Andreas MARZINZIK , Xavier Francois Andre PELLE , Bahaa SALEM , Joseph SCHOEPFER
发明人: Stephanie Kay DODD , Pascal FURET , Robert Martin GROTZFELD , Wolfgang JAHNKE , Darryl Brynley JONES , Paul William MANLEY , Andreas MARZINZIK , Xavier Francois Andre PELLE , Bahaa SALEM , Joseph SCHOEPFER
IPC分类号: C07D213/82 , A61K31/506 , C07D401/14 , C07D401/04 , A61K31/4439 , C07D405/14
CPC分类号: C07D213/82 , A61K31/4439 , A61K31/506 , A61K45/06 , C07D401/04 , C07D401/10 , C07D401/14 , C07D403/10 , C07D405/14 , C07F9/58
摘要: The present invention relates to compounds of formula (I): in which Y, Y1, R1, R2, R3 and R4 are defined in the Summary of the Invention; capable of inhibiting the activity of BCR-ABL1 and mutants thereof. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds in the treatment of cancers.
摘要翻译: 本发明涉及式(I)化合物:其中Y,Y 1,R 1,R 2,R 3和R 4在发明概述中定义; 能够抑制BCR-ABL1及其突变体的活性。 本发明还提供了制备本发明化合物的方法,包含这些化合物的药物制剂和使用这些化合物治疗癌症的方法。
-
7.COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1 有权
标题翻译: 抑制ABL1,ABL2和BCR-ABL1活性的化合物和组合物公开(公告)号:US20130310395A1
公开(公告)日:2013-11-21
申请号:US13892769
申请日:2013-05-13
申请人: Stephanie Kay DODD , Pascal FURET , Robert Martin GROTZFELD , Darryl Brynley JONES , Paul William MANLEY , Andreas MARZINZIK , Xavier Francois Andre PELLE , Bahaa SALEM , Joseph SCHOEPFER
发明人: Stephanie Kay DODD , Pascal FURET , Robert Martin GROTZFELD , Darryl Brynley JONES , Paul William MANLEY , Andreas MARZINZIK , Xavier Francois Andre PELLE , Bahaa SALEM , Joseph SCHOEPFER
IPC分类号: C07D401/10 , A61K31/4439 , C07D405/14 , C07D401/14 , C07D403/10 , A61K45/06 , A61K31/506 , C07F9/58
CPC分类号: C07D213/82 , A61K31/4439 , A61K31/506 , A61K45/06 , C07D401/04 , C07D401/10 , C07D401/14 , C07D403/10 , C07D405/14 , C07F9/58
摘要: The present invention relates to compounds of formula (I): in which Y, Y1, R1, R2, R3 and R4 are defined in the Summary of the Invention; capable of inhibiting the activity of BCR-ABL1 and mutants thereof. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds in the treatment of cancers.
摘要翻译: 本发明涉及式(I)化合物:其中Y,Y 1,R 1,R 2,R 3和R 4在发明概述中定义; 能够抑制BCR-ABL1及其突变体的活性。 本发明还提供了制备本发明化合物的方法,包含这些化合物的药物制剂和使用这些化合物治疗癌症的方法。
-
-
-
-
-
-